STOCK TITAN

[Form 4] Ardelyx, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Michael G. Raab, President & CEO and Director of Ardelyx, Inc. (ARDX), reported a sale of 45,687 shares of common stock on 08/21/2025 at a price of $5.9317 per share. The filing states the sale was an automatic sell-to-cover to satisfy tax withholding upon vesting of restricted stock units. After the transaction, Mr. Raab beneficially owns 1,502,250 shares directly, plus 24,364 shares held in his living trust and 1,000 shares held in trusts for his children. No derivative transactions are reported in this Form 4. The form is signed by an attorney-in-fact and dated 08/25/2025.

Michael G. Raab, Presidente, CEO e Direttore di Ardelyx, Inc. (ARDX), ha comunicato la vendita di 45.687 azioni ordinarie il 21/08/2025 al prezzo di $5,9317 per azione. La segnalazione specifica che si è trattato di una vendita automatica di tipo sell-to-cover per coprire le ritenute fiscali al momento del vesting delle restricted stock unit. Dopo l’operazione, il sig. Raab possiede beneficiariamente 1.502.250 azioni in proprio, più 24.364 azioni detenute dal suo living trust e 1.000 azioni in trust intestati ai figli. Nel modulo non sono riportate transazioni su strumenti derivati. Il Form 4 è firmato da un procuratore e datato 25/08/2025.

Michael G. Raab, Presidente, CEO y Director de Ardelyx, Inc. (ARDX), informó la venta de 45.687 acciones ordinarias el 21/08/2025 a un precio de $5,9317 por acción. El documento indica que la operación fue una venta automática de tipo sell-to-cover para cubrir las retenciones fiscales al consolidarse las restricted stock units. Tras la transacción, el Sr. Raab posee beneficiariamente 1.502.250 acciones en su nombre, además de 24.364 acciones en su living trust y 1.000 acciones en trusts para sus hijos. No se informan operaciones con derivados en este Form 4. El formulario está firmado por un apoderado y fechado el 25/08/2025.

Michael G. Raab, Ardelyx, Inc.(ARDX)의 회장 겸 CEO 겸 이사인 그는 2025-08-21에 보통주 45,687주를 주당 $5.9317에 매도했다고 보고했습니다. 신고서에는 제한주식단위(RSU)의 취득 시 세금 원천징수를 충당하기 위한 자동 sell-to-cover 매도였다고 명시되어 있습니다. 거래 후 Raab 씨는 본인 명의로 1,502,250주를 실질적으로 보유하고 있으며, 생활신탁(living trust)에 24,364주, 자녀들을 위한 신탁에 1,000주가 보관되어 있습니다. 이 Form 4에는 파생상품 거래가 보고되어 있지 않습니다. 양식은 대리인이 서명했으며 2025-08-25자입니다.

Michael G. Raab, président, PDG et administrateur d’Ardelyx, Inc. (ARDX), a déclaré la vente de 45 687 actions ordinaires le 21/08/2025 au prix de 5,9317 $ par action. Le dépôt indique qu’il s’agissait d’une vente automatique de type sell-to-cover afin de couvrir les retenues fiscales lors du vesting des restricted stock units. Après la transaction, M. Raab détient bénéficiairement 1 502 250 actions en propre, ainsi que 24 364 actions dans son living trust et 1 000 actions dans des trusts pour ses enfants. Aucune transaction sur dérivés n’est signalée dans ce Form 4. Le formulaire est signé par un mandataire et daté du 25/08/2025.

Michael G. Raab, Präsident, CEO und Direktor von Ardelyx, Inc. (ARDX), meldete den Verkauf von 45.687 Stammaktien am 21.08.2025 zu einem Kurs von $5,9317 je Aktie. Die Einreichung weist darauf hin, dass es sich um einen automatischen sell-to-cover-Verkauf handelte, um die steuerlichen Abzüge beim Vesting von Restricted Stock Units zu begleichen. Nach der Transaktion hält Herr Raab wirtschaftlich 1.502.250 Aktien direkt, zusätzlich 24.364 Aktien in seinem Living Trust und 1.000 Aktien in Trusts für seine Kinder. In diesem Form 4 werden keine Derivatgeschäfte gemeldet. Das Formular ist von einem Bevollmächtigten unterzeichnet und datiert auf den 25.08.2025.

Positive
  • Sale was disclosed as a sell-to-cover tied to RSU vesting, clarifying the reason for the transaction
  • High retained insider ownership: 1,502,250 shares directly held plus family trust holdings, indicating continued alignment with shareholders
Negative
  • None.

Insights

TL;DR: Routine sell-to-cover on RSU vesting; substantial insider ownership remains.

The reported transaction is a non-derivative sale of 45,687 shares executed solely to cover tax obligations arising from RSU vesting, a common and non-material liquidity event for executives. The filing shows continued concentrated insider ownership with 1,502,250 shares directly held by the reporting person plus additional family trust holdings, which maintains alignment with long-term shareholder interests. No options, warrants, or other derivative activity are disclosed.

TL;DR: Disclosure is consistent with Section 16 requirements; transaction explained as tax withholding.

The Form 4 includes the required narrative explaining the sell-to-cover mechanism tied to RSU vesting, which supports transparency and compliance. The reporting person is both CEO and a director, and the filing delineates direct and indirect holdings including trusts for beneficiaries. The signature by an attorney-in-fact is documented, and no amendments or derivative positions are indicated, suggesting no apparent governance red flags within this filing.

Michael G. Raab, Presidente, CEO e Direttore di Ardelyx, Inc. (ARDX), ha comunicato la vendita di 45.687 azioni ordinarie il 21/08/2025 al prezzo di $5,9317 per azione. La segnalazione specifica che si è trattato di una vendita automatica di tipo sell-to-cover per coprire le ritenute fiscali al momento del vesting delle restricted stock unit. Dopo l’operazione, il sig. Raab possiede beneficiariamente 1.502.250 azioni in proprio, più 24.364 azioni detenute dal suo living trust e 1.000 azioni in trust intestati ai figli. Nel modulo non sono riportate transazioni su strumenti derivati. Il Form 4 è firmato da un procuratore e datato 25/08/2025.

Michael G. Raab, Presidente, CEO y Director de Ardelyx, Inc. (ARDX), informó la venta de 45.687 acciones ordinarias el 21/08/2025 a un precio de $5,9317 por acción. El documento indica que la operación fue una venta automática de tipo sell-to-cover para cubrir las retenciones fiscales al consolidarse las restricted stock units. Tras la transacción, el Sr. Raab posee beneficiariamente 1.502.250 acciones en su nombre, además de 24.364 acciones en su living trust y 1.000 acciones en trusts para sus hijos. No se informan operaciones con derivados en este Form 4. El formulario está firmado por un apoderado y fechado el 25/08/2025.

Michael G. Raab, Ardelyx, Inc.(ARDX)의 회장 겸 CEO 겸 이사인 그는 2025-08-21에 보통주 45,687주를 주당 $5.9317에 매도했다고 보고했습니다. 신고서에는 제한주식단위(RSU)의 취득 시 세금 원천징수를 충당하기 위한 자동 sell-to-cover 매도였다고 명시되어 있습니다. 거래 후 Raab 씨는 본인 명의로 1,502,250주를 실질적으로 보유하고 있으며, 생활신탁(living trust)에 24,364주, 자녀들을 위한 신탁에 1,000주가 보관되어 있습니다. 이 Form 4에는 파생상품 거래가 보고되어 있지 않습니다. 양식은 대리인이 서명했으며 2025-08-25자입니다.

Michael G. Raab, président, PDG et administrateur d’Ardelyx, Inc. (ARDX), a déclaré la vente de 45 687 actions ordinaires le 21/08/2025 au prix de 5,9317 $ par action. Le dépôt indique qu’il s’agissait d’une vente automatique de type sell-to-cover afin de couvrir les retenues fiscales lors du vesting des restricted stock units. Après la transaction, M. Raab détient bénéficiairement 1 502 250 actions en propre, ainsi que 24 364 actions dans son living trust et 1 000 actions dans des trusts pour ses enfants. Aucune transaction sur dérivés n’est signalée dans ce Form 4. Le formulaire est signé par un mandataire et daté du 25/08/2025.

Michael G. Raab, Präsident, CEO und Direktor von Ardelyx, Inc. (ARDX), meldete den Verkauf von 45.687 Stammaktien am 21.08.2025 zu einem Kurs von $5,9317 je Aktie. Die Einreichung weist darauf hin, dass es sich um einen automatischen sell-to-cover-Verkauf handelte, um die steuerlichen Abzüge beim Vesting von Restricted Stock Units zu begleichen. Nach der Transaktion hält Herr Raab wirtschaftlich 1.502.250 Aktien direkt, zusätzlich 24.364 Aktien in seinem Living Trust und 1.000 Aktien in Trusts für seine Kinder. In diesem Form 4 werden keine Derivatgeschäfte gemeldet. Das Formular ist von einem Bevollmächtigten unterzeichnet und datiert auf den 25.08.2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RAAB MICHAEL

(Last) (First) (Middle)
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210

(Street)
WALTHAM MA 02451

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARDELYX, INC. [ ARDX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/21/2025 S(1) 45,687 D $5.9317 1,502,250 D
Common Stock 24,364 I Family Trust(2)
Common Stock 1,000 I Family Trust(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
2. The shares are directly held by Michael G. Raab, Trustee of the Michael G. Raab Living Trust dated July 25, 2012.
3. The shares are owned directly by trusts for the benefit of the Reporting Person's children.
Remarks:
/s/ Elizabeth Grammer, Attorney-in-Fact for Michael Raab 08/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ARDX insider Michael Raab report on Form 4?

He reported a sale of 45,687 common shares on 08/21/2025 at $5.9317 per share, disclosed as a sell-to-cover for RSU tax withholding.

How many ARDX shares does Michael Raab beneficially own after the reported transaction?

He beneficially owns 1,502,250 shares directly, plus 24,364 shares in his living trust and 1,000 shares in trusts for his children.

Was the Form 4 transaction related to options or other derivatives?

No. The Form 4 reports a non-derivative stock sale for tax withholding; no derivative securities are listed.

What position does the reporting person hold at Ardelyx (ARDX)?

The reporting person, Michael G. Raab, is listed as President & CEO and a Director of Ardelyx, Inc.

Who signed the Form 4 filing for Michael Raab and when?

The Form 4 bears the signature of Elizabeth Grammer, Attorney-in-Fact for Michael Raab and is dated 08/25/2025.
Ardelyx

NASDAQ:ARDX

ARDX Rankings

ARDX Latest News

ARDX Latest SEC Filings

ARDX Stock Data

1.47B
234.62M
2.5%
70.98%
10.89%
Biotechnology
Pharmaceutical Preparations
Link
United States
FREMONT